Phase 3 Medical Communications Limited 11725207 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is other publishing activities Digita Accounts Production Advanced 6.30.9574.0 true 11725207 2024-01-01 2024-12-31 11725207 2024-12-31 11725207 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 11725207 bus:Micro-entities 2024-01-01 2024-12-31 11725207 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 11725207 bus:FilletedAccounts 2024-01-01 2024-12-31 11725207 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11725207 bus:RegisteredOffice 2024-01-01 2024-12-31 11725207 bus:CompanySecretary1 2024-01-01 2024-12-31 11725207 bus:Director1 2024-01-01 2024-12-31 11725207 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11725207 bus:Agent1 2024-01-01 2024-12-31 11725207 countries:England 2024-01-01 2024-12-31 11725207 2023-01-01 2023-12-31 11725207 2023-12-31 11725207 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 11725207

Phase 3 Medical Communications Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Phase 3 Medical Communications Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Phase 3 Medical Communications Limited

Company Information

Director

Patricia Forsyth

Company secretary

Nicholas Forsyth

Registered office

1 Park Gardens
Yeovil
Somerset
BA20 1DW

Accountants

Whites
Chartered Accountants1 Park Gardens
Yeovil
Somerset
BA20 1DW

 

Phase 3 Medical Communications Limited

(Registration number: 11725207)
Balance Sheet as at 31 December 2024

2024
£

2023
£

Fixed assets

279,498

278,956

Current assets

100,256

61,651

Creditors: Amounts falling due within one year

(27,673)

(24,005)

Net current assets

72,583

37,646

 

352,081

316,602

Capital and reserves

352,081

316,602

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
1 Park Gardens
Yeovil
Somerset
BA20 1DW
England

These financial statements were authorised for issue by the director on 10 September 2025.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 10 September 2025
 

 

Phase 3 Medical Communications Limited

(Registration number: 11725207)
Balance Sheet as at 31 December 2024

.........................................
Patricia Forsyth
Director